Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.63 |
| ▸ | TSHR | P16473 | 2/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | MMP1 | P03956 | 1/20 | 0.45 |
| ▸ | MMP2 | P08253 | 1/20 | 0.45 |
| ▸ | MMP9 | P14780 | 1/20 | 0.45 |
| ▸ | MMP8 | P22894 | 1/20 | 0.45 |
| ▸ | MMP12 | P39900 | 1/20 | 0.45 |
| ▸ | MMP13 | P45452 | 1/20 | 0.45 |
| ▸ | MMP14 | P50281 | 1/20 | 0.45 |
| ▸ | MMP16 | P51512 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2431833 | 1.00 | CYP1A2 (0.63) | CYP1A2TSHRALDH1A1HSD17B10MMP1 | |
| SCHEMBL3003307 | 0.89 | ALDH1A1 (0.57) | CYP1A2TSHRALDH1A1HSD17B10TDP1 | |
| SCHEMBL27474823 | 0.87 | ALDH1A1 (0.58) | CYP1A2TSHRALDH1A1HSD17B10TDP1 | |
| SCHEMBL28337091 | 0.85 | CYP1A2 (0.54) | CYP1A2TSHRALDH1A1HSD17B10TDP1 | |
| SCHEMBL10717343 | 0.85 | TSHR (0.50) | CYP1A2TSHRALDH1A1TDP1L3MBTL1 | |
| SCHEMBL7733065 | 0.84 | CYP1A2 (0.57) | CYP1A2TSHRALDH1A1HSD17B10TDP1 | |
| SCHEMBL2413159 | 0.84 | ALDH1A1 (0.55) | CYP1A2TSHRALDH1A1HSD17B10TDP1 | |
| SCHEMBL11518980 | 0.84 | ALDH1A1 (0.55) | CYP1A2TSHRALDH1A1HSD17B10TDP1 | |
| SCHEMBL29688451 | 0.84 | ALDH1A1 (0.55) | CYP1A2TSHRALDH1A1HSD17B10TDP1 | |
| SCHEMBL974764 | 0.84 | ALDH1A1 (0.55) | CYP1A2TSHRALDH1A1HSD17B10TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3128838-B1 | PLANT STIMULATORS, USE THEREOF AND METHOD OF PLANT STIMULATION | AGRA GROUP AS (CZ) | 2020-04-29 | — | — | EP | disclosed |
| EP-3128838-A1 | PLANT STIMULATORS, USE THEREOF AND METHOD OF PLANT STIMULATION | Agra Group, A.S. (CZ) | 2017-02-15 | — | — | EP | disclosed |
| WO-2015154732-A1 | PLANT STIMULATORS, USE THEREOF AND METHOD OF PLANT STIMULATION | AGRA GROUP A.S. (CZ) | 2015-10-15 | — | — | WO | disclosed |
| EP-1346982-B1 | VLA-4 INHIBITORS | DAIICHI SEIYAKU CO (JP) | 2011-09-14 | — | — | EP | disclosed |
| EP-0952847-A4 | STABLE BIOCATALYSTS FOR ESTER HYDROLYSIS | THERMOGEN INC (US) | 2003-09-03 | — | — | EP | disclosed |
| US-6218167-B1 | NUCLEIC ACID SEQUENCE ENCODING ESTERASE ENZYMES CHARACTERIZED BY THE ABILITY TO REMAIN STABLE AT CERTAIN TEMPERATURES, SUBSTRATE SPECIFICITIES, AND ACTIVITY PROFILE; CELLS TRANSFORMED WITH NUCLEIC ACID | THERMOGEN, INC. | 2001-04-17 | — | — | US | disclosed |
| US-6218163-B1 | PURIFIED ESTERASE ISOLATED FROM THERMUS, BACILLUS, OR ACTINOMYCES; RESOLUTION OF RACEMIC MIXTURES/DRUGS | THERMOGEN, INC. | 2001-04-17 | — | — | US | disclosed |
| EP-1073668-A2 | SOLUTION PHASE BIOPOLYMER SYNTHESIS | Köster, Hubert (US) | 2001-02-07 | — | — | EP | disclosed |
| EP-1005556-A2 | STABLE BIOCATALYSTS FOR ESTER HYDROLYSIS | Thermogen, Inc. (US) | 2000-06-07 | — | — | EP | disclosed |
| WO-1999055718-A2 | SOLUTION PHASE BIOPOLYMER SYNTHESIS | KOESTER HUBERT (US) | 1999-11-04 | — | — | WO | disclosed |
| US-5969121-A | NUCLEIC ACID SEQUENCE THAT ENCODES ESTERASE PROTEIN FOR COMMERCIAL USE | THERMOGEN, INC. (US) | 1999-10-19 | — | — | US | disclosed |
| WO-1998046770-A9 | STABLE BIOCATALYSTS FOR ESTER HYDROLYSIS | — | 1999-03-18 | — | — | WO | disclosed |
| WO-1998046770-A2 | STABLE BIOCATALYSTS FOR ESTER HYDROLYSIS | THERMOGEN, INC. (US) | 1998-10-22 | — | — | WO | disclosed |
| WO-1997025058-A1 | STABLE BIOCATALYSTS FOR ESTER HYDROLYSIS | THERMOGEN, INC. (US) | 1997-07-17 | — | — | WO | disclosed |
| US-5164499-A | Nitroaryl carbonyl compounds, nitrodihydroaryl carbonyl intermediates thereto, and processes | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-11-17 | — | — | US | disclosed |
| EP-0211759-B1 | Pyrimido[2,1-b]benzothiazole derivatives and their salts, process for their preparation, use as medicaments and compositions containing them | ROUSSEL-UCLAF (FR) | 1991-04-17 | — | — | EP | disclosed |
| US-4912220-A | Mixing a nitroaryl compound with an unsaturated silane under anhydrous conditions; adding a fluoride compound and an electrophilic compound | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-03-27 | — | — | US | disclosed |
| US-4743690-A | NITROARYL COMPOUND, SILANE, FLUORO ONIUM COMPOUND, BROMIDE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1988-05-10 | — | — | US | disclosed |
| US-4659862-A | Process of preparing nitrodihydroaryl carbonyl compounds | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-04-21 | — | — | US | disclosed |
| EP-0211759-A2 | Pyrimido[2,1-b]benzothiazole derivatives and their salts, process for their preparation, use as medicaments and compositions containing them | ROUSSEL-UCLAF (FR) | 1987-02-25 | — | — | EP | disclosed |